Patent Covering Endograft Device Is Obvious, Petitioner Tells Patent Board

(September 29, 2021, 1:26 PM EDT) -- ALEXANDRIA, Va. — In a Sept. 28 petition for inter partes review filed with the Patent Trial and Appeal Board, a medical technology company asserts that a patented endograft device is rendered obvious by the petitioner’s own patent....

Attached Documents

Related Sections